Cargando…
Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders
Long‐term management of urea cycle disorders (UCDs) often involves unlicensed oral sodium benzoate (NaBz) which has a high volume and unpleasant taste. A more palatable treatment is licenced and available (glycerol phenylbutyrate [GPB], Ravicti) but guidance on how to transition patients from NaBz i...
Autores principales: | Yeo, Mildrid, Rehsi, Preeya, Dorman, Megan, Grunewald, Stephanie, Baruteau, Julien, Chakrapani, Anupam, Footitt, Emma, Prunty, Helen, McSweeney, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898712/ https://www.ncbi.nlm.nih.gov/pubmed/35281661 http://dx.doi.org/10.1002/jmd2.12274 |
Ejemplares similares
-
Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre
por: Yeo, Mildrid, et al.
Publicado: (2023) -
A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate
por: Köse, Melis, et al.
Publicado: (2017) -
Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain
por: Martín-Hernández, Elena, et al.
Publicado: (2022) -
Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment
por: Baruteau, Julien, et al.
Publicado: (2019) -
Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts
por: van Straten, Giora, et al.
Publicado: (2019)